Center for Outcomes Research, Real World Evidence and Epidemiology (CORE) Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Genmab · 1 month ago

Center for Outcomes Research, Real World Evidence and Epidemiology (CORE) Intern

positionPrinceton
timeInternship
remoteHybrid
seniorityIntern
workcardStart in 2026 Summer

Genmab is an international biotechnology company dedicated to improving patient lives through innovative antibody therapeutics. The CORE Intern will work on strategy and projects to demonstrate the value of an oncology product approaching launch, gaining exposure to HEOR, RWE, and Medical Affairs teams.

BiotechnologyHealth CareManufacturingMedical
check
Culture & Values
check
H1B Sponsor Likelynote

Responsibilities

Conduct literature search/review re: unmet needs, treatment guidelines, impact of treatment on clinical, economic, patient reported outcomes
Lead HEOR research projects providing input on study design, data analysis and results
Develop/Present (power point slides) on research-related topics to an extended or cross-functional team
Assist in preparations for medical planning and launch planning as appropriate
Assist in preparations for early scientific advice as appropriate

Qualification

SAS/R ProgrammingEpidemiologyAnalytical skillsOncology experienceAI tools for HEORCommunication skillsOrganizational skillsTime management

Required

PhD student who has completed course work towards a PhD degree in Epidemiology, Economics, Public Health, Pharmaceutical Policy or a closely related area
Strong analytical skills with the ability to translate key insights into strategy / tactics
Organized and detail-oriented
Excellent time management, verbal & written communication skills
Proficiency in SAS/R Programming and experience in working with claims and electronic health record datasets

Preferred

Experience in oncology therapeutic area
Experience using AI tools for HEOR analyses

Company

Genmab

twittertwittertwitter
company-logo
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
dateFounded in 1999
location
Copenhagen, Hovedstaden, DNK
people-size1001-5000 employees
web-link
https://www.genmab.com

H1B Sponsorship

Genmab has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (10)
2023 (6)
2022 (3)
2021 (3)
2020 (1)

Funding

Current Stage
Public Company
Total Funding
$11.7B
Key Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M

Leadership Team

leader-logo
Anthony Pagano
Chief Financial Officer
linkedin
leader-logo
Anthony Mancini
EVP & Chief Operating Officer
linkedin

Recent News

Pharma Letter
The week in pharma: action, reaction and insight – week to January 16, 2026
2026-01-19
Investing.com
Genmab stock falls after Phase 3 epcoritamab trial misses key endpoint
2026-01-19
BioSpace
AbbVie, Genmab’s Bispecific Misses Key Overall Survival Endpoint in Phase III Lymphoma Study
2026-01-19
Company data provided by crunchbase